6 results
Summary of characteristics of Platelet Aggregation Inhibitors

#AntiPlatelet #Inhibitors #Pharmacology #Table #Overview #Interactions #Pharmacology #Cardiology
Summary of characteristics ... #Pharmacology # ... Table #Overview ... #Interactions #Pharmacology ... #Cardiology
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
Summary of characteristics ... AND DRUG INTERACTIONS ... #Medications #Cardiology ... #Pharmacology # ... Management #Therapy #Table
Summary of Diuretic Agents 
Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction
CARBONIC ANHYDRASE
Summary of Diuretic ... Pharmacokinetics, Toxicities, Interaction ... others SGLT2 INHIBITORS ... #Medications #Pharmacology ... #summary #table
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
inducers (↑) and inhibitors ... concentrations, and inhibitors ... by inducers or inhibitors ... #Chemotherapy # ... #Table #Pharmacology
Allopurinol Pharmacology Summary

Xanthine oxidase inhibitor blocking the formation of new uric acid
Initiate 1-2 days prior to
Allopurinol Pharmacology ... Summary Xanthine ... oxidase inhibitor ... days prior to chemotherapy ... hypersensitivity Drug interactions
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Cardiovascular Drug-Drug Interactions ... Angiotensin-Converting Enzyme Inhibitors ... Monoamine Oxidase Inhibitors ... supplementals #herbal #pharmacology ... #DDI #table #cardiology